167 related articles for article (PubMed ID: 33569344)
1. Risk and Prognosis of Secondary Bladder Cancer After Radiation Therapy for Rectal Cancer: A Large Population-Based Cohort Study.
Guan X; Wei R; Yang R; Lu Z; Liu E; Zhao Z; Chen H; Yang M; Liu Z; Jiang Z; Wang X
Front Oncol; 2020; 10():586401. PubMed ID: 33569344
[TBL] [Abstract][Full Text] [Related]
2. Risk and prognosis of secondary bladder cancer after radiation therapy for pelvic cancer.
Li S; Wei R; Yu G; Liu H; Chen T; Guan X; Wang X; Jiang Z
Front Oncol; 2022; 12():982792. PubMed ID: 36091158
[TBL] [Abstract][Full Text] [Related]
3. Increased risk of secondary bladder cancer after radiation therapy for endometrial cancer.
Wen L; Zhong G; Ren M
Sci Rep; 2022 Jan; 12(1):1032. PubMed ID: 35058550
[TBL] [Abstract][Full Text] [Related]
4. Risk and prognosis of secondary breast cancer after radiation therapy for non-Hodgkin lymphoma: a massive population-based analysis.
Lv X; Yue P; Zhou F
Clin Transl Oncol; 2023 May; 25(5):1307-1314. PubMed ID: 36478146
[TBL] [Abstract][Full Text] [Related]
5. Risk and prognosis of secondary bladder cancer after post-operative radiotherapy for gynecological cancer.
Wen L; Zhong G; Zhang Y; Zhong M
Bosn J Basic Med Sci; 2022 Jun; 22(3):471-480. PubMed ID: 34716699
[TBL] [Abstract][Full Text] [Related]
6. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.
Krasnow RE; Rodríguez D; Nagle RT; Mossanen M; Kibel AS; Chang SL
Urol Oncol; 2018 Nov; 36(11):500.e11-500.e19. PubMed ID: 30249519
[TBL] [Abstract][Full Text] [Related]
7. Risk and prognosis of second corpus uteri cancer after radiation therapy for pelvic cancer: A population-based analysis.
Yu G; Wei R; Li S; Wang Y; Liu H; Chen T; Guan X; Wang X; Jiang Z
Front Oncol; 2022; 12():957608. PubMed ID: 36249002
[TBL] [Abstract][Full Text] [Related]
8. Risk and prognosis of secondary esophagus cancer after radiotherapy for breast cancer.
Sun Q; Chen Y; Li T; Ni B; Zhu X; Xu B; Li J
Sci Rep; 2023 Mar; 13(1):3968. PubMed ID: 36894590
[TBL] [Abstract][Full Text] [Related]
9. Risk and Prognosis of Secondary Rectal Cancer After Radiation Therapy for Pelvic Cancer.
Yang R; Guan X; Liu E; Wei R; Zhao Z; Chen H; Liu Z; Yang M; Jiang Z; Wang X
Front Oncol; 2020; 10():584072. PubMed ID: 33194727
[TBL] [Abstract][Full Text] [Related]
10. Risk and prognosis of secondary thoracic cancers after radiation therapy for esophageal cancer.
Yi H; Li S; Lin Y; Li F; Wang S; Jin D; Lv Z; Fu L; Mao Y
J Gastroenterol Hepatol; 2023 Jun; 38(6):930-939. PubMed ID: 36811199
[TBL] [Abstract][Full Text] [Related]
11. Association of Radiotherapy for Rectal Cancer and Second Gynecological Malignant Neoplasms.
Guan X; Wei R; Yang R; Lu Z; Liu E; Zhao Z; Chen H; Yang M; Liu Z; Jiang Z; Wang X
JAMA Netw Open; 2021 Jan; 4(1):e2031661. PubMed ID: 33416884
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
[TBL] [Abstract][Full Text] [Related]
13. Secondary Primary Cancer Risk After Radiation Therapy in Rectal Cancer: A Population-Based Cohort Study With Propensity Score Matching.
Schlesinger-Raab A; Schubert-Fritschle G; Kim M; Werner J; Belka C; Wolff H; Agha A; Fuchs M; Friess H; Combs S; Häussler B; Engel J; Halfter K
Clin Colorectal Cancer; 2023 Dec; 22(4):485-495.e3. PubMed ID: 37838522
[TBL] [Abstract][Full Text] [Related]
14. Superior survival for breast-conserving therapy over mastectomy in patients with breast cancer: A population-based SEER database analysis across 30 years.
Ke S; Wang W; Li B; Feng X; Yan D; Liu J
Front Oncol; 2022; 12():1032063. PubMed ID: 36686746
[TBL] [Abstract][Full Text] [Related]
15. Radiation Therapy Changed the Second Malignancy Pattern in Rectal Cancer Survivors.
Ye X; Tan Y; Ma R; Lou P; Yuan Y
Medicina (Kaunas); 2023 Aug; 59(8):. PubMed ID: 37629753
[No Abstract] [Full Text] [Related]
16. Secondary Breast Cancer Risk by Radiation Volume in Women With Hodgkin Lymphoma.
Conway JL; Connors JM; Tyldesley S; Savage KJ; Campbell BA; Zheng YY; Hamm J; Pickles T
Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):35-41. PubMed ID: 27979454
[TBL] [Abstract][Full Text] [Related]
17. Risk and prognosis of second cutaneous melanoma after radiotherapy for breast cancer: A population-based analysis.
Luo T; Zhang Y; Chen T; Cai Y; Yang Z
Biomol Biomed; 2024 Jan; ():. PubMed ID: 38197802
[TBL] [Abstract][Full Text] [Related]
18. Persistent muscle-invasive bladder cancer after neoadjuvant chemotherapy: an analysis of Surveillance, Epidemiology and End Results-Medicare data.
Lane G; Risk M; Fan Y; Krishna S; Konety B
BJU Int; 2019 May; 123(5):818-825. PubMed ID: 30126053
[TBL] [Abstract][Full Text] [Related]
19. Increased Burden of Second Bladder Cancer and Rectal Cancer in Prostate Cancer Treated With Radiotherapy: Results From Surveillance, Epidemiology, and End Results.
Lin J; Zhan X; Chen R; Chen T; Jiang M; Li Y; Liu X; Chen G; Fu B
Cancer Control; 2023; 30():10732748231177544. PubMed ID: 37196346
[TBL] [Abstract][Full Text] [Related]
20. Association of Radioiodine for Differentiated Thyroid Cancer and Second Breast Cancer in Female Adolescent and Young Adult.
Zhao X; Chen M; Qi X; Zhu H; Yang G; Guo Y; Dong Q; Yang Q
Front Endocrinol (Lausanne); 2021; 12():805194. PubMed ID: 35154006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
